AIT (allergen immunotherapy): A model for the "precision medicine"

Clinical and Molecular Allergy

Volumn 13, Issue 1, 2015, Pages

  Passalacqua, Giovanni ^a   Canonica, Giorgio Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Allergen immunotherapy; Personalized medicine; Precision medicine

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGEN IMMUNOTHERAPY; ALLERGIC REACTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; PERSONALIZED MEDICINE; QUALITY OF LIFE; SUBLINGUAL IMMUNOTHERAPY;

EID: 84959148355     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/s12948-015-0028-6     Document Type: Article

References (30)

1. Corpus Hyppocraticum (1839) Émile Littré: Oeuvres Completes (Traduction Nouvelle, avec le texte grec en regard), vol I. J.-B. Baillière, Paris
2. Harvey W (1628) Exercitatio Anatomica de Motu Cordis et Sanguinis in animalibus. Sp Coll Hunterian Y.7.13, Frankfurt
3. Virchow RK (1858) Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebenlehre, Berlin
4. Lister J (1967) Antiseptic principle in the practice of surgery. Br Med J 2(5543):9-12
5. Brasier AR (2013) Identification of innate immune response endotypes in asthma: implications for personalized medicine. Curr Allergy Asthma Rep 13:462-468
6. Agache IO (2013) From phenotypes to endotypes to asthma treatment. Curr Opin Allergy Clin Immunol 13:249-256
7. Bieber T (2013) Stratified medicine. Future Medicine Ltd. ISBN: 978-1-78084-318-6
8. Braido F, Holgate S, Canonica GW (2012) From "Blockbusters" to "biosimilars": an opportunity for patients, medical specialists and health care providers. Pulm Pharmacol Ther 25:483
9. Fuchs VR (2013) The gross domestic product and health care spending. N Engl J Med 369(2):107-109
10. Hamburg MA, Collins FS (2010) The path to personalized medicine. N Engl J Med 363:301-304
11. Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D et al (2014) Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med 190:175-184
12. Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG (2014) Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc 11(4):531-536
13. Liu Y, Zhang S, Li DW, Jiang SJ (2013) Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials. PLoS One 8(3):e59872. doi: 10.1371/journal.pone.0059872(Epub 2013 Mar 27)
14. Agusti A (2014) The path to personalised medicine in COPD. Thorax 69:857-864
15. Fajt ML, Wenzel SE (2015) Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 135:299-310
16. Akdis CA, Akdis M (2015) Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J 8(1):17
17. 2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 6(1):17. doi: 10.1186/1939-4551-6-17
18. Sastre J (2013) Molecular diagnosis and immunotherapy. Curr Opin Allergy Clin Immunol 13:646-650
19. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M et al (2013) Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 131(5):1288-1296
20. Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S et al (2014) Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 7(1):6
21. Passalacqua G, Canonica GW (2015) Allergen immunotherapy: focus on tablets. Ann Allergy Asthma Immunol 115:4-9
22. Passalacqua G (2011) Specific immunotherapy: beyond the clinical scores. Ann Allergy Asthma Immunol 107:401-406
23. Hankin CS, Cox L (2014) Allergy immunotherapy: what is the evidence for cost saving? Curr Opin Allergy Clin Immunol 14:363-370
24. Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W et al (2015) International consensus on allergy immunotherapy. J Allergy Clin Immunol. doi: 10.1016/j.jaci.2015.04.047
25. Kaul S, May SL, Vieths S (2011) Regulatory environment for allergen-specific immunotherapy. Allergy 66:753-764
26. Bonini S (2012) Regulatory aspects of allergen-specific immunotherapy: Europe sets the scene for a global approach. World Allergy Organ J 5:120-123
27. Jameson JL, Longo LS (2015) Precision medicine: personalized, problematic and promising. N Eng J Med 372:2229-2234
28. Gustafsson M, Colm EN, Zhang H, Barabási AL, Baranzini S, Brunak S et al (2014) Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Med 6:82
29. Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J et al (2011) Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 3(7):43
30. Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A et al (2014) Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 44:304-323